Vascular Biogenics Ltd. - ADR

Stock Card

$0.17

$-5.82 (-97.19%)

As on 16-Oct-2023 19:58EDT

Market cap

$12 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Vascular Biogenics - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-9 Mln
ROE

-0.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.5
Debt to Equity

0
Book Value

$--
EPS

$-0.2
Face value

--
Shares outstanding

77,640,496

10 Years Aggregate

CFO

$-165.60 Mln

EBITDA

$-193.20 Mln

Net Profit

$-201.29 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Vascular Biogenics - ADR	40.0	-28.2	-42.9	28.2	-48.8	-34.5	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8

As on 16-Oct-2023 | *As on 28-Aug-2026

Company	2022	2021	2020	2019	2018	2017	2016
Vascular Biogenics - ADR	-93.9	4.2	57.5	23.7	-86.2	46.4	-7.8
BSE Sensex	4.4	22.0	15.8	14.4	5.9	27.9	1.9
BSE Sensex	4.4	22.0	15.8	14.4	5.9	27.9	1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Vascular Biogenics - ADR

Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory... indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel. Read more

CEO & Director

Prof. Dror Harats M.D.
CEO & Director

Prof. Dror Harats M.D.
Headquarters

Hevel Modi'in
Website

https://www.vblrx.com

FAQs for Vascular Biogenics - ADR

What is the current share price of Vascular Biogenics Ltd - ADR Today?

The share price of Vascular Biogenics Ltd - ADR is $0.17 (NASDAQ) as of 16-Oct-2023 19:58 EDT. Vascular Biogenics Ltd - ADR has given a return of -48.78% in the last 3 years.

What is the current PB & PE ratio of Vascular Biogenics Ltd - ADR?

Since, TTM earnings of Vascular Biogenics Ltd - ADR is negative, P/E ratio is not available.
The P/B ratio of Vascular Biogenics Ltd - ADR is 0.35 times as on 16-Nov-2023, a 88 discount to its peers’ median range of 2.84 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-0.29	0.41
2021	-4.82	2.65
2020	-4.05	3.19
2019	-2.19	1.21
2018	-1.70	0.66

What is the 52 Week High and Low of Vascular Biogenics Ltd - ADR?

The 52-week high and low of Vascular Biogenics Ltd - ADR are Rs -- and Rs -- as of 29-Aug-2026.

What is the market cap of Vascular Biogenics Ltd - ADR?

Vascular Biogenics Ltd - ADR has a market capitalisation of $ 12 Mln as on 16-Nov-2023. As per SEBI classification, it is a company.

Should I invest in Vascular Biogenics Ltd - ADR?

Before investing in Vascular Biogenics Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.